ZYME Q3 2020 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena

ZYMEZymeworks Inc.

$2B

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-66.4% YoY

Gross Profit

-$52M-1958.3% margin

Operating Income

-$74M-2788.3% margin

Net Income

-$73M-2745.4% margin

EPS (Diluted)

$-1.43

QoQ Revenue Growth

-78.6%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$19M

Stock-Based Comp.

$19M

Balance Sheet

Total Assets

$572M

Total Liabilities

$139M

Stockholders' Equity

$432M

Cash & Equivalents

$244M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$8M	-66.4%
Gross Profit	-$52M	-$21M	-142.0%
Operating Income	-$74M	-$34M	-119.6%
Net Income	-$73M	-$30M	-138.1%

Revenue Segments

Other Product

$3M100%